gulose
RN given refers to cpd without isomeric designation
Also Known As:
gulose, (D)-isomer; gulose, (L)-isomer
Networked: 2
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
| 1. | Cao, Yongjun:
1 article
(12/2021)
|
| 2. | Chen, Wenming:
1 article
(12/2021)
|
| 3. | Huang, Weiping:
1 article
(12/2021)
|
| 4. | Li, Houkai:
1 article
(12/2021)
|
| 5. | Liao, Guohao:
1 article
(12/2021)
|
| 6. | Qi, Dongxia:
1 article
(12/2021)
|
| 7. | Wang, Meizhu:
1 article
(12/2021)
|
| 8. | Wang, Xiaoyang:
1 article
(12/2021)
|
| 9. | Ye, Wenchong:
1 article
(12/2021)
|
| 10. | Zhou, Cui:
1 article
(12/2021)
|
Related Diseases
| 1. | Lung Neoplasms (Lung Cancer)
12/15/2021
- " A gulose moiety contributes to the belomycin (BLM) disaccharide selective targeting to lung cancer cells." 12/15/2021
- " Taken together, the monosacharide d-gulose conjugate offers a new strategy for solving cytotoxic drugs via the increased tumor targeting in the therapy of lung cancer." 08/01/2019
- " L-(+)-gulose, phosphatidylethanolamine (PE)(22:2(13Z,16Z)/15:0), cysteinyl-glutamine, S-japonin, threoninyl-glutamine, chlorate, 3-oxoadipic acid, dukunolide A, and malonic semialdehyde levels were observed to be elevated in serum samples of lung cancer cases when compared to those of healthy controls. "
|
| 2. | Neoplasms (Cancer)
|
|
Related Drugs and Biologics
Related Therapies and Procedures